View in EDS

Targeting TREX1 Induces Innate Immune Response in Drug-Resistant Small-Cell Lung Cancer.

Saved in:
Bibliographic Details
Title: Targeting TREX1 Induces Innate Immune Response in Drug-Resistant Small-Cell Lung Cancer.
Authors: Murayama T; Nuclear Dynamics and Cancer Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.; Cancer Epigenetics Institute, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Mahadevan NR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts., Meador CB; Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, Massachusetts., Ivanova EV; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Pan Y; Nuclear Dynamics and Cancer Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.; Cancer Epigenetics Institute, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Knelson EH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Tani T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Nakayama J; Department of Oncogenesis and Growth Regulation, Osaka International Cancer Institute, Osaka, Japan.; Laboratory of Integrative Oncology, National Cancer Center Research Institute, Tokyo, Japan., Ma X; Nuclear Dynamics and Cancer Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.; Cancer Epigenetics Institute, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Thai TC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Hung YP; Department of Pathology, Massachusetts General Hospital Cancer Center, Boston, Massachusetts., Kim W; Moores Cancer Center, UC San Diego, La Jolla, California.; Center for Novel Therapeutics, UC San Diego, La Jolla, California.; Department of Medicine, UC San Diego, La Jolla, California., Watanabe H; Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Cai KQ; Histopathology Facility, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Hata AN; Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, Massachusetts., Paweletz CP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Barbie DA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Cañadas I; Nuclear Dynamics and Cancer Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.; Cancer Epigenetics Institute, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
Source: Cancer research communications [Cancer Res Commun] 2024 Sep 01; Vol. 4 (9), pp. 2399-2414.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9918281580506676 Publication Model: Print Cited Medium: Internet ISSN: 2767-9764 (Electronic) Linking ISSN: 27679764 NLM ISO Abbreviation: Cancer Res Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39177280
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Targeting TREX1 Induces Innate Immune Response in Drug-Resistant Small-Cell Lung Cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Murayama+T%22">Murayama T</searchLink>; Nuclear Dynamics and Cancer Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.; Cancer Epigenetics Institute, Fox Chase Cancer Center, Philadelphia, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Mahadevan+NR%22">Mahadevan NR</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Meador+CB%22">Meador CB</searchLink>; Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Ivanova+EV%22">Ivanova EV</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Pan+Y%22">Pan Y</searchLink>; Nuclear Dynamics and Cancer Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.; Cancer Epigenetics Institute, Fox Chase Cancer Center, Philadelphia, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Knelson+EH%22">Knelson EH</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Tani+T%22">Tani T</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Nakayama+J%22">Nakayama J</searchLink>; Department of Oncogenesis and Growth Regulation, Osaka International Cancer Institute, Osaka, Japan.; Laboratory of Integrative Oncology, National Cancer Center Research Institute, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Ma+X%22">Ma X</searchLink>; Nuclear Dynamics and Cancer Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.; Cancer Epigenetics Institute, Fox Chase Cancer Center, Philadelphia, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Thai+TC%22">Thai TC</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Hung+YP%22">Hung YP</searchLink>; Department of Pathology, Massachusetts General Hospital Cancer Center, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Kim+W%22">Kim W</searchLink>; Moores Cancer Center, UC San Diego, La Jolla, California.; Center for Novel Therapeutics, UC San Diego, La Jolla, California.; Department of Medicine, UC San Diego, La Jolla, California.<br /><searchLink fieldCode="AU" term="%22Watanabe+H%22">Watanabe H</searchLink>; Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.<br /><searchLink fieldCode="AU" term="%22Cai+KQ%22">Cai KQ</searchLink>; Histopathology Facility, Fox Chase Cancer Center, Philadelphia, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Hata+AN%22">Hata AN</searchLink>; Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Paweletz+CP%22">Paweletz CP</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Barbie+DA%22">Barbie DA</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Cañadas+I%22">Cañadas I</searchLink>; Nuclear Dynamics and Cancer Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.; Cancer Epigenetics Institute, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229918281580506676%22">Cancer research communications</searchLink> [Cancer Res Commun] 2024 Sep 01; Vol. 4 (9), pp. 2399-2414.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9918281580506676 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2767-9764 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2227679764%22">27679764 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Res Commun <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39177280
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/2767-9764.CRC-24-0360
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2399
    Titles:
      – TitleFull: Targeting TREX1 Induces Innate Immune Response in Drug-Resistant Small-Cell Lung Cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Murayama T
      – PersonEntity:
          Name:
            NameFull: Mahadevan NR
      – PersonEntity:
          Name:
            NameFull: Meador CB
      – PersonEntity:
          Name:
            NameFull: Ivanova EV
      – PersonEntity:
          Name:
            NameFull: Pan Y
      – PersonEntity:
          Name:
            NameFull: Knelson EH
      – PersonEntity:
          Name:
            NameFull: Tani T
      – PersonEntity:
          Name:
            NameFull: Nakayama J
      – PersonEntity:
          Name:
            NameFull: Ma X
      – PersonEntity:
          Name:
            NameFull: Thai TC
      – PersonEntity:
          Name:
            NameFull: Hung YP
      – PersonEntity:
          Name:
            NameFull: Kim W
      – PersonEntity:
          Name:
            NameFull: Watanabe H
      – PersonEntity:
          Name:
            NameFull: Cai KQ
      – PersonEntity:
          Name:
            NameFull: Hata AN
      – PersonEntity:
          Name:
            NameFull: Paweletz CP
      – PersonEntity:
          Name:
            NameFull: Barbie DA
      – PersonEntity:
          Name:
            NameFull: Cañadas I
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2024 Sep 01
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2767-9764
          Numbering:
            – Type: volume
              Value: 4
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: Cancer research communications
              Type: main
ResultId 1